Selective Catalytic Reduction (SCR) Catalyst Market to Reach US$ 4.7 Billion by 2032| Fact.MR Report
May 23, 2023 13:00 ET
|
FACT.MR
Rockville , May 23, 2023 (GLOBE NEWSWIRE) -- As per the latest report by Fact.MR, a market research and competitive intelligence provider, the global selective catalytic reduction (SCR) catalyst...
Catalyst Market Set to Experience a Promising Growth, to Sustain a CAGR of 4.2% During 2022-2032 | Market.us Report
April 04, 2023 11:59 ET
|
Market.Us
New York, April 04, 2023 (GLOBE NEWSWIRE) -- The global catalyst market size was valued at USD 24.4 Bn in 2022, and it is expected to grow to USD 36.4 Bn in the forecast period 2023-2032 with an...
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
March 08, 2023 11:20 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
NewHydrogen begins prototyping of a hydrogen generator
October 11, 2022 03:01 ET
|
NewHydrogen, Inc.
SANTA CLARITA, Calif, Oct. 11, 2022 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC:NEWH), the developer of a green hydrogen generator (electrolyzer), today reported that it has begun the prototype...
NewHydrogen’s focus on lowering the cost of green hydrogen will help accelerate the transition to green energy
May 17, 2022 03:01 ET
|
NewHydrogen, Inc.
SANTA CLARITA, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC:NEWH), the developer of a green hydrogen generator, today stated that the latest trends point to hydrogen produced from...
Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update
May 10, 2022 16:11 ET
|
Catalyst Pharmaceuticals, Inc.
Achieved Record Revenues of more than $43 Million, a 42.7% Increase YoY Three New Patents Issued; Now Five Orange-Book Listed Patents for FIRDAPSE® Significant Cash Position of $198 Million and...
Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®
March 11, 2022 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 11, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies
March 08, 2022 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Catalyst Market Size to Reach $57.5 Billion by 2030 | CAGR: 4.9%: AMR
September 09, 2021 09:00 ET
|
Allied Market Research
Portland, OR, Sept. 09, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global catalyst market generated $35.5 billion in 2020, and is expected to reach...
Gotransverse Joins TM Forum to Promote Intelligent Billing as Part of Open Telecommunications and Networking Solutions
August 31, 2021 08:45 ET
|
Gotransverse
AUSTIN, Texas, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Gotransverse (http://gotransverse.com), a leading provider of enterprise order-to-cash solutions, has joined TM Forum, a non-profit global industry...